NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for COHANCE is Neutral → (mild move); technical trend down-trend; trading at ₹411.60 (-6.05% today); neutral (RSI 37).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | Down-trend (since 2025-04-25) |
| Price | ₹411.60 |
| Change today | -6.05% |
| RSI (14) | 37.10 |
| Relative volume | 0.04 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹16,859 Cr |
| P/E | 160.24 |
| Cap category | Mid Cap |
| 52-week high | -61.6% away |
| 52-week low | +47.0% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for COHANCE (COHANCE LIFESCIENCES LTD) is Neutral with a mild move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
COHANCE's RSI is neutral (RSI 37). A reading above 70 is typically overbought and below 30 oversold.
COHANCE is trading about 62% below its 52-week high and 47% above its 52-week low as of Aug 14 2026, 6:50 PM.
COHANCE's market capitalisation is ₹16,859 Cr as of Aug 14 2026, 6:50 PM.
COHANCE is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.